Cochrane Evidence Synthesis and Methods ►

Methylxanthine for preventing morbidity and mortality in preterm infants: a network meta-analysis

This is a protocol for a Cochrane Review (intervention). The objectives are as follows:

To determine the effects of methylxanthines (caffeine; theophylline or aminophylline) and 'no methylxanthine administration' on morbidity and mortality in preterm infants, using network meta-analysis.

This is a protocol.

Published:

18 December 2023

Authors:

Kinoshita M, Del Giovane C, Mitra S, Hall R, Soll R, Bruschettini M

See the full Review on

the Cochrane Library

►

Was this helpful? Donate.

If you found this evidence helpful, please consider donating to Cochrane. We are a charity that produces accessible evidence to help people make health and care decisions.
Donate
Print
PDF
Citation
Kinoshita M, Del Giovane C, Mitra S, Hall R, Soll R, Bruschettini M. Methylxanthine for preventing morbidity and mortality in preterm infants: a network meta-analysis (Protocol). Cochrane Database of Systematic Reviews 2023, Issue 12. Art. No.: CD015058. DOI: 10.1002/14651858.CD015058.